Week in Review: Evidence is Lacking for Use of Oral Antibiotics in Rhinosinusitis

Top news of the week from Pharmacy Times®.

5. Pharmacists Are Essential to Maintaining Immunizations During Pandemic

In a recent Pharmacy Times® webcast, several experts discussed how pharmacists’ roles are changing and some of the new precautions implemented at pharmacies during the coronavirus disease 2019 (COVID-19) pandemic. Read more.

4. Scientists Predict COVID-19 to Become Seasonal Virus in Near Future

Researchers predict COVID-19 will likely become a seasonal virus, diminishing in the summer and emerging in the winter months, according to a recent study. Read more.

3. What to Expect from a Specialty Pharmacy Partner

Clinical education, strong data analytics, and valuing collaboration are the best ways to provide patient support and access to specialty pharmaceutical manufacturers. Read more.

2. Regulatory and Legislative Actions Currently Impacting the 340B Program

Protections for covered entities under the 340B program will most likely be affected by decisions in the Senate, according to a virtual panel at the National Association of Specialty Pharmacy Annual Meeting and Expo 2020. Read more.

1. Evidence is Lacking for Use of Oral Antibiotics in Rhinosinusitis

Despite being commonly prescribed, experts have found very little evidence to support the use of oral antibiotics for allergic and chronic rhinosinusitis. Read here.